Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
Abstract Background Ovarian cancer (OC) is characterized by its rapid growth and spread which, accompanied by a low 5-year survival rate, necessitates the development of improved treatments. In ovarian cancer, the selective overexpression of Mucin-16 (MUC16, CA125) in tumor cells highlights its pote...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2024-04-01
|
| Saila: | Journal of Translational Medicine |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12967-024-05174-y |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|